Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-01-11FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc. to update labeling.
-
FDA approval · 2017-01-06FDA Approved: FANAPT — Supplemental Application (Vanda Pharmaceuticals Inc.)
The FDA approved a supplemental application for Fanapt (iloperidone) submitted by Vanda Pharmaceuticals Inc.
-
FDA approval · 2016-12-27FDA Approved: ZIPRASIDONE HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved BluePoint Laboratories' ziprasidone hydrochloride as a generic from an Abbreviated New Drug Application. The approval covers th…
-
FDA approval · 2016-11-29FDA Approved: CLOZAPINE — Original Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma's generic Clozapine under an original ANDA, authorizing its use as a treatment for schizophrenia (including tr…
-
FDA approval · 2016-11-28FDA Approved: ILOPERIDONE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved an original application for iloperidone by Mylan Pharmaceuticals, a generic antipsychotic indicated for schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-18FDA Approved: RISPERDAL CONSTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for RISPERDAL CONSTA (risperidone) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2016-11-18FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for fluphenazine decanoate filed by Endo USA, Inc., resulting in an approved regulatory action for t…
-
FDA approval · 2016-11-08FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Fresenius Kabi USA, LLC)
The FDA approved a supplemental application for Fluphenazine Decanoate from Fresenius Kabi USA, LLC.
-
FDA approval · 2016-11-01FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original application for quetiapine fumarate, granting marketing authorization for a generic versi…
-
FDA approval · 2016-10-27FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) by Eli Lilly and Company, resulting in updated labeling t…
-
FDA approval · 2016-10-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for aripiprazole from Torrent Pharmaceuticals Limited, enabling a generic version of the drug.
-
FDA approval · 2016-10-17FDA Approved: PERPHENAZINE — Original Application (Actavis Pharma, Inc.)
FDA approved Actavis Pharma's generic Perphenazine (perphenazine) under an original ANDA (ANDA207582), marking its first approval as a gener…
-
FDA approval · 2016-10-07FDA Approved: ARIPIPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's generic aripiprazole (ANDA 204111) based on its original application.
-
FDA approval · 2016-10-06FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
The FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) from H2-Pharma LLC.
-
FDA approval · 2016-10-06FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) by Eli Lilly and Company to support the intramuscular for…
-
FDA approval · 2016-09-29FDA Approved: ARIPIPRAZOLE — Original Application (Dr.Reddys Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' generic aripiprazole under an original ANDA application. This action provides a generic option for th…
-
FDA approval · 2016-09-23FDA Approved: REXULTI — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Rexulti (brexpiprazole) from Otsuka America Pharmaceutical, Inc., under NDA 205422.
-
FDA approval · 2016-09-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Mylan Institutional LLC)
The FDA granted a supplemental approval to Mylan Institutional LLC for haloperidol decanoate, a long-acting injectable antipsychotic. The ac…
-
FDA approval · 2016-09-12FDA Approved: ARIPIPRAZOLE — Original Application (Quallent Pharmaceuticals Health LLC)
The FDA approved the original ANDA for a generic aripiprazole from Quallent Pharmaceuticals Health LLC. The approval covers a generic versio…
-
FDA approval · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC. This action confirms approval …
-
FDA approval · 2016-08-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2016-08-18FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
FDA approves a supplemental application for ABILIFY MAINTENA (aripiprazole) from Otsuka America Pharmaceutical, Inc.
-
FDA approval · 2016-08-18FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc.
-
FDA approval · 2016-08-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for aripiprazole from Apotex Corp., authorizing a generic version of the drug. This action represent…
-
FDA approval · 2016-07-08FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc.